Ezetimibe and Lamictal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe and Lamictal. Common interactions include abdominal pain upper among females and convulsion among males.

The phase IV clinical study analyzes what interactions people who take Ezetimibe and Lamictal have. It is created by eHealthMe based on reports of 16 people who take Ezetimibe and Lamictal from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jun, 30, 2022

16 people who take Ezetimibe and Lamictal together, and have interactions are studied.


What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 16,276 Ezetimibe users for its effectiveness, alternative drugs and more.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 74,513 Lamictal users for its effectiveness, alternative drugs and more.

Number of Ezetimibe and Lamictal reports submitted per year:

Ezetimibe and Lamictal drug interactions.

Common Ezetimibe and Lamictal drug interactions by gender *:

female:

  1. Abdominal pain upper
  2. Agitation
  3. Arthritis
  4. Dry mouth
  5. Exophthalmos
  6. Exostosis
  7. Fibromyalgia
  8. Hallucination
  9. Inflammation
  10. Injection site pain

male:

  1. Convulsion
  2. Drug eruption
  3. Rash vesicular
  4. Regurgitation
  5. Seborrhoeic keratosis
  6. Somnolence
  7. Toxic skin eruption
  8. Xerosis
  9. Epidermal necrosis
  10. Fatigue

Common Ezetimibe and Lamictal drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Confusional state
  2. Convulsion
  3. Fatigue
  4. Headache
  5. Hypoglycaemia
  6. Malaise
  7. Nausea
  8. Regurgitation
  9. Somnolence

50-59:

  1. Anaemia
  2. Somnolence

60+:

  1. Abdominal pain upper
  2. Agitation
  3. Septic shock
  4. Thrombocytopenia
  5. Tremor
  6. Drug eruption
  7. Drug hypersensitivity
  8. Epidermal necrosis
  9. Lymphadenopathy
  10. Rash maculo-papular

Common conditions people have *:

  1. High Blood Pressure: 8 people, 50.00%
  2. Muscle Spasms (muscle contraction): 6 people, 37.50%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 37.50%
  4. Insomnia (sleeplessness): 6 people, 37.50%
  5. Hypersensitivity: 6 people, 37.50%
  6. Depression: 5 people, 31.25%
  7. Pain: 5 people, 31.25%
  8. Cardiac Failure Congestive: 4 people, 25.00%
  9. Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 25.00%
  10. Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Lamictal?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ezetimibe and Lamictal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ezetimibe interactions:

Browse all interactions between Ezetimibe and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Lamictal interactions:

Browse all interactions between Lamictal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe and lamotrigine (the active ingredients of Ezetimibe and Lamictal, respectively), and Ezetimibe and Lamictal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: